{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:03:48Z","timestamp":1792699428295,"version":"4.5.0"},"reference-count":134,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["JRSM Cardiovascular Disease"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) affects up to nearly a third of the Western population and has been inconsistently associated with cardiovascular diseases (CVDs). Therefore, we conducted a comprehensive meta-analysis to quantify the correlation of NAFLD with all major vascular diseases, acute coronary syndrome (ACS), subclinical atherosclerosis and endothelial dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed and Embase for studies looking at the relationship between NAFLD and cardiovascular diseases published through September 2023. The parameters we used to assess cardiovascular diseases include acute coronary syndrome, brachial flow-mediated dilatation (FMD), serum asymmetric dimethylarginine (ADMA), carotid intima-media thickness (CIMT), and carotid stenosis (&gt;50%). Data from these studies were then collected and meta-analysis was performed using the random effects model. RevMan v5.4 was used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We interrogated a total of 114 publications which met our inclusion criteria. NAFLD patients showed statistically significant reduction in FMD% [MD: \u22124.83 (95% CI: \u22125.84 to 3.81,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)] and increased serum ADMA [MD: 0.08 (95% CI: 0.05\u20130.11,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)]. Mean CIMT was also increased in NAFLD patients [MD 0.13 (95% CI: 0.12\u20130.14,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)]. NAFLD showed a higher prevalence of pathological CIMT [MD: 0.11 (95% CI: 0.10\u20130.12,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)] and increased carotid plaques [OR: 2.08 (95% CI: 1.52\u20132.86,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)]. Furthermore, we demonstrated statistically significant increase in cardiovascular diseases among NAFLD patients compared to controls [OR: 1.92 (95% CI: 1.53\u20132.41,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.00001)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NAFLD is a strong predictor for endothelial dysfunction, subclinical atherosclerosis and cardiovascular disease. Further studies are required to determine whether incidental findings of fatty liver on abdominal ultrasonography should prompt the need for detailed assessment of other CVD risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20480040251325929","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T16:59:27Z","timestamp":1742576367000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-alcoholic fatty liver disease (NAFLD) and its association to cardiovascular disease: A comprehensive meta-analysis"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9274-484X","authenticated-orcid":false,"given":"Irina Lubomirova","family":"Mladenova","sequence":"first","affiliation":[{"name":"Imperial College School of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Fon","family":"Tan","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yong","family":"Ng","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Sharma","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Research, Royal Holloway University, Egham, Greater London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i7.1712"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"e_1_3_2_4_2","first-page":"643","article-title":"Nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems","volume":"22","author":"Tiniakos DG","year":"2010","unstructured":"Tiniakos DG. Nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Eur J Gastroenterol Hepatol 2010; 22: 643\u2013650.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26717"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2538"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2007.05.013"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea A","year":"2005","unstructured":"Brea A, Mosquera D, Mart\u00edn E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045\u20131050.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2247"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4254\/wjh.v5.i11.621","article-title":"Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome","volume":"5","author":"Tziomalos K","year":"2013","unstructured":"Tziomalos K, Giampatzis V, Bouziana SD, et al. Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. World J Hepatol 2013; 5: 621\u2013626.","journal-title":"World J Hepatol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clinre.2017.01.005","article-title":"Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation","volume":"41","author":"Cetinda\u011fl\u0131 I","year":"2017","unstructured":"Cetinda\u011fl\u0131 I, Kara M, Tanoglu A, et al. Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Res Hepatol Gastroenterol 2017; 41: 516\u2013524.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345681"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835a58b1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031799","article-title":"Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease","volume":"7","author":"Chiang CH","year":"2012","unstructured":"Chiang CH, Huang PH, Chung FP, et al. Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One 2012; 7: e31799.","journal-title":"PLoS One"},{"key":"e_1_3_2_16_2","first-page":"48","article-title":"Abdominal obesity is an independent risk factor for increased carotid intima-media thickness in obese children","volume":"53","author":"Hacihamdio\u011flu B","year":"2011","unstructured":"Hacihamdio\u011flu B, Okutan V, Yozgat Y, et al. Abdominal obesity is an independent risk factor for increased carotid intima-media thickness in obese children. Turk J Pediatr 2011; 53: 48\u201354.","journal-title":"Turk J Pediatr"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2013.814734"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1758-5996-6-109","article-title":"A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease","volume":"6","author":"Sayki Arslan M","year":"2014","unstructured":"Sayki Arslan M, Turhan S, Dincer I, et al. A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. Diabetol Metab Syndr 2014; 6: 109.","journal-title":"Diabetol Metab Syndr"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12020-012-9712-1","article-title":"Assessment of endothelial function in patients with nonalcoholic fatty liver disease","volume":"43","author":"Colak Y","year":"2013","unstructured":"Colak Y, Senates E, Yesil A, et al. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine 2013; 43: 100\u2013107.","journal-title":"Endocrine"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7869\/tg.2012.101","article-title":"Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease","volume":"34","author":"Guleria A","year":"2013","unstructured":"Guleria A, Duseja A, Kalra N, et al. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop Gastroenterol 2013; 34: 74\u201382.","journal-title":"Trop Gastroenterol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/HJH.0000000000001285","article-title":"Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease","volume":"35","author":"Li X","year":"2017","unstructured":"Li X, Shi H, Wang Z, et al. Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. J Hypertens 2017; 35: 1226\u20131234.","journal-title":"J Hypertens"},{"key":"e_1_3_2_22_2","first-page":"1825142","article-title":"Endothelial dysfunction, a marker of atherosclerosis, is independent of metabolic syndrome in NAFLD patients","author":"Narayan J","year":"2020","unstructured":"Narayan J, Das HS, Nath P, et al. Endothelial dysfunction, a marker of atherosclerosis, is independent of metabolic syndrome in NAFLD patients. Int J Hepatol 2020: 1825142. doi:https:\/\/doi.org\/10.1155\/2020\/1825142","journal-title":"Int J Hepatol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2015.04.009","article-title":"Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men","volume":"240","author":"Ozturk K","year":"2015","unstructured":"Ozturk K, Uygun A, Guler AK, et al. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. Atherosclerosis 2015; 240: 380\u2013386.","journal-title":"Atherosclerosis"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003280","article-title":"Steatosis grade is the most important risk factor for development of endothelial dysfunction in NAFLD","volume":"95","author":"Sapmaz F","year":"2016","unstructured":"Sapmaz F, Uzman M, Basyigit S, et al. Steatosis grade is the most important risk factor for development of endothelial dysfunction in NAFLD. Medicine (Baltimore) 2016; 95: e3280.","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1445-5994.2007.01481.x","article-title":"Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease","volume":"38","author":"Senturk O","year":"2008","unstructured":"Senturk O, Kocaman O, Hulagu S, et al. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J 2008; 38: 183\u2013189.","journal-title":"Intern Med J"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2012.06.005","article-title":"Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians","volume":"223","author":"Thakur ML","year":"2012","unstructured":"Thakur ML, Sharma S, Kumar A, et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 2012; 223: 507\u2013511.","journal-title":"Atherosclerosis"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20781"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.144"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.07.027"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.6000\/1927-5129.2013.09.42","article-title":"Carotid intima-Media thickness in patients with non-alcoholic fatty liver disease","volume":"9","author":"Shaikh AH","year":"2013","unstructured":"Shaikh AH, Aatif S, Ahmed T. Carotid intima-Media thickness in patients with non-alcoholic fatty liver disease. J Basic Appl Sci 2013; 9: 333.","journal-title":"J Basic Appl Sci"},{"key":"e_1_3_2_31_2","first-page":"661","article-title":"Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease","volume":"7","author":"Mohammadi A","year":"2011","unstructured":"Mohammadi A, Sedani HH, Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag 2011; 7: 661\u2013665.","journal-title":"Vasc Health Risk Manag"},{"key":"e_1_3_2_32_2","first-page":"351","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes","volume":"59","author":"Agarwal AK","year":"2011","unstructured":"Agarwal AK, Jain V, Singla S, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011; 59: 351\u2013354.","journal-title":"J Assoc Physicians India"},{"key":"e_1_3_2_33_2","first-page":"2","article-title":"Carotid artery intima-Media thickness and nonalcoholic fatty liver disease severity","volume":"2","author":"Albricker ACL","year":"2014","unstructured":"Albricker ACL, Couto CA, Nunes MCP, et al. Carotid artery intima-Media thickness and nonalcoholic fatty liver disease severity. J Cardiovasc Dis Diagn 2014; 2: 2.","journal-title":"J Cardiovasc Dis Diagn"},{"issue":"1","key":"e_1_3_2_34_2","first-page":"491","article-title":"Carotid Intima Media Thickness (CIMT) in Nondiabetic Patients with non Alcoholic Fatty Liver Disease (NAFLD)","volume":"79","author":"Algarem NH","year":"2011","unstructured":"Algarem NH, Amin MA, Fawzi MM, et al. Carotid Intima Media Thickness (CIMT) in Nondiabetic Patients with non Alcoholic Fatty Liver Disease (NAFLD). Med J Cairo Univ 2011; 79(1): 491\u2013496.","journal-title":"Med J Cairo Univ"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cjca.2012.07.846","article-title":"Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents","volume":"29","author":"Alp H","year":"2013","unstructured":"Alp H, Karaarslan S, Selver Eklio\u011flu B, et al. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol 2013; 29: 1118\u20131125.","journal-title":"Can J Cardiol"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10620-007-9998-7","article-title":"Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease","volume":"53","author":"Aygun C","year":"2008","unstructured":"Aygun C, Kocaman O, Sahin T, et al. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1352\u20131357.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.artres.2008.08.399","article-title":"P2.33: adiponectin hormone, hypertension and endothelial dysfunction in non-alcoholic fatty liver disease patients","volume":"2","author":"Baou K","year":"2008","unstructured":"Baou K, Vlachopoulos C, Manesis E, et al. P2.33: adiponectin hormone, hypertension and endothelial dysfunction in non-alcoholic fatty liver disease patients. Artery Res 2008; 2: 114.","journal-title":"Artery Res"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00059-012-3714-x","article-title":"Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis","volume":"38","author":"Ba\u015far O","year":"2013","unstructured":"Ba\u015far O, Akbal E, K\u00f6kl\u00fc S, et al. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz 2013; 38: 417\u2013422.","journal-title":"Herz"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case\u2013control study","volume":"25","author":"Brea A","year":"2005","unstructured":"Brea A, Mosquera D, Mart\u00edn E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case\u2013control study. Arterioscler, Thromb, Vasc Biol 2005; 25: 1045\u20131050.","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2013-303992.136","article-title":"ASSA13-10-11 Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis","volume":"99","author":"Li-Ying C","year":"2013","unstructured":"Li-Ying C, Li-Zheng F, Qiao-Hua Q, et al. ASSA13-10-11 Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis. Heart 2013; 99: A45.","journal-title":"Heart"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/kjhep.2008.14.1.77","article-title":"Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis","volume":"14","author":"Choi SY","year":"2008","unstructured":"Choi SY, Kim D, Kang JH, et al. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol 2008; 14: 77\u201388.","journal-title":"Korean J Hepatol"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0b013e3283513f19","article-title":"Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease","volume":"24","author":"Colak Y","year":"2012","unstructured":"Colak Y, Karabay CY, Tuncer I, et al. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2012; 24: 613\u2013618.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPG.0b013e31816232c9","article-title":"Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease","volume":"47","author":"Demircioglu F","year":"2008","unstructured":"Demircioglu F, Ko\u00e7yigit A, Arslan N, et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008; 47: 68\u201375.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/MEG.0000000000001431","article-title":"Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease","volume":"31","author":"Dogan T","year":"2019","unstructured":"Dogan T, Ozturk K, Celikkanat S, et al. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2019; 31: 1460\u20131466.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/13813455.2019.1661496","article-title":"Low level of adiponectin predicts the development of nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?","volume":"128","author":"Ebrahimi R","year":"2022","unstructured":"Ebrahimi R, Shanaki M, Mohassel Azadi S, et al. Low level of adiponectin predicts the development of nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices? Arch Physiol Biochem 2022; 128(1): 24\u201331.","journal-title":"Arch Physiol Biochem"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2007.08.041","article-title":"Carotid artery intima-media thickness in nonalcoholic fatty liver disease","volume":"121","author":"Fracanzani AL","year":"2008","unstructured":"Fracanzani AL, Burdick L, Raselli S, et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 2008; 121: 72\u201378.","journal-title":"Am J Med"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.01.016"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00246-012-0447-9","article-title":"The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children","volume":"34","author":"G\u00f6k\u00e7e S","year":"2013","unstructured":"G\u00f6k\u00e7e S, Atbinici Z, Aycan Z, et al. The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. Pediatr Cardiol 2013; 34: 308\u2013315.","journal-title":"Pediatr Cardiol"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2010.500062"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202666","article-title":"Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: a cross-sectional, population-based study in middle-aged subjects","volume":"13","author":"Gummesson A","year":"2018","unstructured":"Gummesson A, Str\u00f6mberg U, Schmidt C, et al. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: a cross-sectional, population-based study in middle-aged subjects. PLoS One 2018; 13: e0202666.","journal-title":"PLoS One"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.09.008"},{"key":"e_1_3_2_52_2","first-page":"84","article-title":"Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis","volume":"55","author":"Genc H","year":"2013","unstructured":"Genc H, Dogru T, Celebi G, et al. Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis. G\u00fcLhane Tip Dergisi 2013; 55: 84.","journal-title":"G\u00fcLhane Tip Dergisi"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3923\/ijom.2015.35.41","article-title":"Correlation between non-alcoholic fatty liver disease and carotid intima-Media thickness in patient with type II diabetes","volume":"8","author":"Hanafi M","year":"2015","unstructured":"Hanafi M, Cina M, Zakerkish M, et al. Correlation between non-alcoholic fatty liver disease and carotid intima-Media thickness in patient with type II diabetes. Int J Osteoporosis Metab Disord 2015; 8: 35\u201341.","journal-title":"Int J Osteoporosis Metab Disord"},{"key":"e_1_3_2_54_2","first-page":"31","article-title":"The association between nonalcoholic fatty liver disease of the older and carotid atherosclerosis","volume":"1","author":"Han H","year":"2012","unstructured":"Han H, Gao Y, Xu L. The association between nonalcoholic fatty liver disease of the older and carotid atherosclerosis. J Aerospace Med 2012; 1: 31\u201334.","journal-title":"J Aerospace Med"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1161\/ATVBAHA.112.252957","article-title":"Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese","volume":"32","author":"Huang Y","year":"2012","unstructured":"Huang Y, Bi Y, Xu M, et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 2012; 32: 2321\u20132326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10083409"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4250\/jcu.2012.20.3.126","article-title":"Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients","volume":"20","author":"Kang JH","year":"2012","unstructured":"Kang JH, Im Cho K, Kim SM, et al. Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients. J Cardiovasc Ultrasound 2012; 20: 126.","journal-title":"J Cardiovasc Ultrasound"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3126\/njh.v16i1.23898","article-title":"Non alcoholic fatty liver disease is a predictor of subclinical carotid atherosclerosis in the presence of metabolic syndrome","volume":"16","author":"Kemaloglu C","year":"2019","unstructured":"Kemaloglu C, Kemaloglu MD. Non alcoholic fatty liver disease is a predictor of subclinical carotid atherosclerosis in the presence of metabolic syndrome. Nepalese Heart J 2019; 16: 39\u201345.","journal-title":"Nepalese Heart J"},{"key":"e_1_3_2_59_2","first-page":"163","article-title":"Nonalcoholic fatty liver disease as a risk factor for cardiovascular disease: using the estimation of Framingham risk score and carotid artherosclerosis","volume":"12","author":"Keum SH","year":"2012","unstructured":"Keum SH, Lee KM, Jung SP. Nonalcoholic fatty liver disease as a risk factor for cardiovascular disease: using the estimation of Framingham risk score and carotid artherosclerosis. Korean J Health Promot 2012; 12: 163\u2013169.","journal-title":"Korean J Health Promot"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.09.012"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ13-0269"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population","volume":"100","author":"Kim NH","year":"2014","unstructured":"Kim NH, Park J, Kim SH, et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 2014; 100: 938\u2013943.","journal-title":"Heart"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jc.2013-4133","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance","volume":"99","author":"Kim S-K","year":"2014","unstructured":"Kim S-K, Choi YJ, Huh BW, et al. Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab 2014; 99: 1879\u20131884.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/oby.21076","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity","volume":"23","author":"Koot BG","year":"2015","unstructured":"Koot BG, de Groot E, van der Baan-Slootweg OH, et al. Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity. Obesity (Silver Spring) 2015; 23: 1239\u20131243.","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"e_1_3_2_65_2","first-page":"2888","article-title":"Assessment of carotid lesions in nonalcoholic fatty liver disease patients","volume":"2","author":"Sathish Kumar A","year":"2014","unstructured":"Sathish Kumar A, Sridhar K, Srinivas M, et al. Assessment of carotid lesions in nonalcoholic fatty liver disease patients. J Med Sci Clin Res 2014; 2(11): 2888\u20132901.","journal-title":"J Med Sci Clin Res"},{"key":"e_1_3_2_66_2","first-page":"2854","article-title":"Study of the relationship between nonalcoholic fatty liver disease and carotid atherosclerosis in type 2 diabetics","volume":"11","author":"Lin M-X","year":"2010","unstructured":"Lin M-X, Luo M-Q, Chen Z-C, et al. Study of the relationship between nonalcoholic fatty liver disease and carotid atherosclerosis in type 2 diabetics. Chin J Health Laboratory Technol 2010; 11: 2854\u20132855.","journal-title":"Chin J Health Laboratory Technol"},{"key":"e_1_3_2_67_2","first-page":"547","article-title":"[Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity]","volume":"12","author":"Liu LR","year":"2010","unstructured":"Liu LR, Fu JF, Liang L, et al. [Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity]. Zhongguo Dang Dai Er Ke Za Zhi 2010; 12: 547\u2013550.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000355808","article-title":"Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients","volume":"39","author":"Mikolasevic I","year":"2014","unstructured":"Mikolasevic I, Racki S, Zaputovic L, et al. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. Kidney Blood Pressure Res 2014; 39: 308\u2013314.","journal-title":"Kidney Blood Pressure Res"},{"key":"e_1_3_2_69_2","first-page":"661","article-title":"Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease","volume":"7","author":"Mohammadi A","year":"2011","unstructured":"Mohammadi A, Sedani HH, Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag 2011; 7: 661.","journal-title":"Vasc Health Risk Manag"},{"key":"e_1_3_2_70_2","doi-asserted-by":"crossref","DOI":"10.5812\/iranjradiol.14260","article-title":"Association of non-alcoholic fatty liver disease with increased carotid intima-media thickness considering other cardiovascular risk factors","volume":"16","author":"Mohammadzadeh A","year":"2019","unstructured":"Mohammadzadeh A, Shahkarami V, Shakiba M, et al. Association of non-alcoholic fatty liver disease with increased carotid intima-media thickness considering other cardiovascular risk factors. Iran J Radiol 2019; 16: e14260.","journal-title":"Iran J Radiol"},{"key":"e_1_3_2_71_2","first-page":"55","article-title":"Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis","volume":"7","author":"Nahandi MZ","year":"2014","unstructured":"Nahandi MZ, Khoshbaten M, Ramazanzadeh E, et al. Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. Gastroenterol Hepatol Bed Bench 2014; 7: 55\u201362.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0031-1283218","article-title":"Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease","volume":"20","author":"Neri S","year":"2011","unstructured":"Neri S, Signorelli S, Scuderi R, et al. Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol 2011; 20: 149.","journal-title":"Int J Angiol"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.05.028"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001059"},{"key":"e_1_3_2_75_2","first-page":"205","article-title":"Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects","volume":"163","author":"Pagano A","year":"2012","unstructured":"Pagano A, Vecchio C, Giangreco E, et al. Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects. Clin Ter 2012; 163: 205\u2013210.","journal-title":"Clin Ter"},{"key":"e_1_3_2_76_2","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(13)61354-9","article-title":"1355 Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients","volume":"58","author":"Pais R","year":"2013","unstructured":"Pais R, Bellentani S, Bugianessi E, et al. 1355 Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients. J Hepatol 2013; 58: S545.","journal-title":"J Hepatol"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0541"},{"key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4318\/tjg.2012.0489","article-title":"Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease","volume":"23","author":"Pinarba\u015fi B","year":"2012","unstructured":"Pinarba\u015fi B, Dem\u0131r K, Oflaz H, et al. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease. Turk J Gastroenterol 2012; 23: 720\u2013726.","journal-title":"Turk J Gastroenterol"},{"key":"e_1_3_2_79_2","first-page":"215","article-title":"Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus","volume":"13","author":"Poanta LI","year":"2011","unstructured":"Poanta LI, Albu A, Fodor D. Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. Med Ultrason 2011; 13: 215\u2013219.","journal-title":"Med Ultrason"},{"key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cen.12698","article-title":"Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity","volume":"83","author":"Puig J","year":"2015","unstructured":"Puig J, Blasco G, Daunis IEJ, et al. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clin Endocrinol (Oxf) 2015; 83: 180\u2013186.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3748\/wjg.15.4770","article-title":"Carotid lesions in outpatients with nonalcoholic fatty liver disease","volume":"15","author":"Ramilli S","year":"2009","unstructured":"Ramilli S, Pretolani S, Muscari A, et al. Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol 2009; 15: 4770\u20134774.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4103\/jfmpc.jfmpc_957_19","article-title":"Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals","volume":"9","author":"Rampally V","year":"2020","unstructured":"Rampally V, Biri SK, Nair IK, et al. Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. J Family Med Prim Care 2020; 9: 1182.","journal-title":"J Family Med Prim Care"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833a7de6"},{"key":"e_1_3_2_84_2","first-page":"35","article-title":"Sonographic evaluation of mean carotid intima-media thickness of patients with moderate to severe nonalcoholic fatty liver disease","volume":"42","author":"Sanei-Sistani S","year":"2011","unstructured":"Sanei-Sistani S, Elahifar MA, Javadi-Nodehi S, et al. Sonographic evaluation of mean carotid intima-media thickness of patients with moderate to severe nonalcoholic fatty liver disease. ZJRMS 2011; 42: 35\u201338.","journal-title":"ZJRMS"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12478"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12539"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.03.056"},{"issue":"1","key":"e_1_3_2_88_2","first-page":"26","article-title":"Non-alcoholic fatty liver disease as a cardiovascular risk factor","volume":"21","author":"EM S","year":"2010","unstructured":"EM S, AA M, Farouk A,Non-alcoholic fatty liver disease as a cardiovascular risk factor. El-Minia Medical Bulletin 2010; 21(1): 26\u201341.","journal-title":"El-Minia Medical Bulletin"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0135"},{"key":"e_1_3_2_90_2","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/diacare.27.10.2498","article-title":"Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation","volume":"27","author":"Targher G","year":"2004","unstructured":"Targher G, Bertolini L, Padovani R, et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004; 27: 2498\u20132500.","journal-title":"Diabetes Care"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349177"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.01.021"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2012.02823.x"},{"key":"e_1_3_2_94_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1567-5688(08)70360-X","article-title":"Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients?","volume":"1","author":"Torres D","year":"2008","unstructured":"Torres D, Parrinello G, Paterna S, et al. Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients? Atherosclerosis 2008; 1: 90.","journal-title":"Atherosclerosis"},{"key":"e_1_3_2_95_2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.052","article-title":"The influence of abdominal and ectopic fat accumulation on carotid intima-Media thickness: a Chongqing study","volume":"27","author":"Yi X","year":"2018","unstructured":"Yi X, Liu YH, Zhou XF, et al. The influence of abdominal and ectopic fat accumulation on carotid intima-Media thickness: a Chongqing study. J Stroke Cerebrovasc Dis 2018; 27: 1992\u20131997.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"e_1_3_2_96_2","first-page":"1","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients","volume":"6","author":"Zhang L","year":"2016","unstructured":"Zhang L, Guo K, Lu J, et al. Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients. Sci Rep 2016; 6: 1\u20138.","journal-title":"Sci Rep"},{"key":"e_1_3_2_97_2","first-page":"365","article-title":"Research on the carotid artery intima-media thickness in nonalcoholic fatty liver disease","volume":"5","author":"Zhou X","year":"2009","unstructured":"Zhou X, Guo Z, Wang C. Research on the carotid artery intima-media thickness in nonalcoholic fatty liver disease. Chinese J Health Care Med 2009; 5: 365\u2013367.","journal-title":"Chinese J Health Care Med"},{"key":"e_1_3_2_98_2","doi-asserted-by":"crossref","first-page":"108873","DOI":"10.1016\/j.diabres.2021.108873","article-title":"Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease","volume":"177","author":"Wang B","year":"2021","unstructured":"Wang B, Zhao Z, Liu S, et al. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease. Diabetes Res Clin Pract 2021; 177: 108873.. Epub 2021 May 26. PMID: 34051282.","journal-title":"Diabetes Res Clin Pract"},{"key":"e_1_3_2_99_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253298","article-title":"Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease","volume":"16","author":"Sukahri S","year":"2021","unstructured":"Sukahri S, Mohamed Shah FZ, Ismail AI, et al. Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. PLoS One 2021; 16: e0253298.. PMID: 34191823; PMCID: PMC8244858.","journal-title":"PLoS One"},{"key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"102560","DOI":"10.1016\/j.dsx.2022.102560","article-title":"Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD","volume":"16","author":"Shabbirhussain BV","year":"2022","unstructured":"Shabbirhussain BV, Singh S, Dixit VK, et al. Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD. Diabetes Metab Syndr 2022; 16: 102560. Epub 2022 Jul 1. PMID: 35816948.","journal-title":"Diabetes Metab Syndr"},{"key":"e_1_3_2_101_2","first-page":"129","article-title":"Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population","volume":"46","author":"Taharboucht S","year":"2021","unstructured":"Taharboucht S, Guermaz R, Brouri M, et al. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population. J Med Vasc 2021; 46: 129\u2013138.. Epub 2021 Apr 20. PMID: 33990287.","journal-title":"J Med Vasc"},{"key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsha.2013.07.004","article-title":"Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events","volume":"25","author":"El Azeem HA","year":"2013","unstructured":"El Azeem HA, Khalek ESA, El-Akabawy H, et al. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc 2013; 25: 239\u2013246.","journal-title":"J Saudi Heart Assoc"},{"key":"e_1_3_2_103_2","first-page":"273","article-title":"Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography","volume":"9","author":"A\u00e7ikel M","year":"2009","unstructured":"A\u00e7ikel M, Sunay S, Koplay M, et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg 2009; 9: 273\u2013279.","journal-title":"Anadolu Kardiyol Derg"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000401"},{"key":"e_1_3_2_105_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clinre.2014.02.009","article-title":"Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population","volume":"38","author":"Chan WK","year":"2014","unstructured":"Chan WK, Tan AT, Vethakkan SR, et al. Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol 2014; 38: 284\u2013291.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i10.1579"},{"key":"e_1_3_2_107_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01192-4","article-title":"Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study","volume":"20","author":"Ichikawa K","year":"2021","unstructured":"Ichikawa K, Miyoshi T, Osawa K, et al. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. Cardiovasc Diabetol 2021; 20: 1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/QAI.0000000000002359","article-title":"Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV","volume":"84","author":"Kaplan A","year":"2020","unstructured":"Kaplan A, Simon TG, Henson JB, et al. Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV. J Acquir Immune Defic Syndr 2020; 84: 400\u2013404.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05986-9"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-014-0796-9"},{"key":"e_1_3_2_111_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.arcmed.2009.07.009","article-title":"High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease","volume":"40","author":"Lu H","year":"2009","unstructured":"Lu H, Zeng L, Liang B, et al. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res 2009; 40: 571\u2013575.","journal-title":"Arch Med Res"},{"key":"e_1_3_2_112_2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn DH","year":"2020","unstructured":"Sinn DH, Kang D, Chang Y, et al. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study. J Gastroenterol Hepatol 2020; 35: 833\u2013839.","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_3_2_113_2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study","volume":"4","author":"Pisto P","year":"2014","unstructured":"Pisto P, Santaniemi M, Bloigu R, et al. Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 2014; 4: e004973.","journal-title":"BMJ Open"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.12.039"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.08.021"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.030"},{"key":"e_1_3_2_117_2","first-page":"535","article-title":"Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease","volume":"35","author":"Targher G","year":"2012","unstructured":"Targher G, Pichiri I, Zoppini G, et al. Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. J Endocrinol Invest 2012; 35: 535\u2013540.","journal-title":"J Endocrinol Invest"},{"key":"e_1_3_2_118_2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1148\/radiol.2019181793","article-title":"Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET\/CT","volume":"291","author":"Vita T","year":"2019","unstructured":"Vita T, Murphy DJ, Osborne MT, et al. Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET\/CT. Radiology 2019; 291: 330\u2013337.","journal-title":"Radiology"},{"key":"e_1_3_2_119_2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong VW","year":"2011","unstructured":"Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011; 60: 1721\u20131727.","journal-title":"Gut"},{"key":"e_1_3_2_120_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12072-015-9607-3","article-title":"Association between retinal artery lesions and nonalcoholic fatty liver disease","volume":"9","author":"Yang W","year":"2015","unstructured":"Yang W, Xu H, Yu X, et al. Association between retinal artery lesions and nonalcoholic fatty liver disease. Hepatol Int 2015; 9: 278\u2013282.","journal-title":"Hepatol Int"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20220514"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14597"},{"key":"e_1_3_2_123_2","first-page":"376","article-title":"The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome","volume":"36","author":"Alper AT","year":"2008","unstructured":"Alper AT, Hasdemir H, Sahin S, et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2008; 36: 376\u2013381.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"e_1_3_2_124_2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.4103\/0366-6999.241797","article-title":"Association between nonalcoholic fatty liver disease and carotid artery disease in a community-based Chinese population: a cross-sectional study","volume":"131","author":"Guo YC","year":"2018","unstructured":"Guo YC, Zhou Y, Gao X, et al. Association between nonalcoholic fatty liver disease and carotid artery disease in a community-based Chinese population: a cross-sectional study. Chin Med J (Engl) 2018; 131: 2269\u20132276.","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.09090769"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1753-0407.12172","article-title":"Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2","volume":"7","author":"Idilman IS","year":"2015","unstructured":"Idilman IS, Akata D, Hazirolan T, et al. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2. J Diabetes 2015; 7: 279\u2013286.","journal-title":"J Diabetes"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.05.039"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23789"},{"issue":"2","key":"e_1_3_2_130_2","article-title":"Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis","volume":"8","author":"Wong MYZ","year":"2021","unstructured":"Wong MYZ, Yap JJL, Sultana R, et al. Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis. Open Heart 2021; 8(2): e001850.","journal-title":"Open Heart"},{"key":"e_1_3_2_131_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12902-023-01460-w","article-title":"Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes","volume":"23","author":"Montazeri Z","year":"2023","unstructured":"Montazeri Z, Hashemi-Madani N, Iraji H, et al. Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes. BMC Endocr Disord 2023; 23: 202.","journal-title":"BMC Endocr Disord"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13419"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24452"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i23.7392"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01686-8"}],"container-title":["JRSM Cardiovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20480040251325929","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20480040251325929","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20480040251325929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T17:01:50Z","timestamp":1742576510000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20480040251325929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":134,"alternative-id":["10.1177\/20480040251325929"],"URL":"https:\/\/doi.org\/10.1177\/20480040251325929","relation":{},"ISSN":["2048-0040","2048-0040"],"issn-type":[{"value":"2048-0040","type":"print"},{"value":"2048-0040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"article-number":"20480040251325929"}}